Global Allergy Diagnostic Sales Market Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Allergy Diagnostic Sales Market Report 2024
Market Analysis and InsightsGlobal Allergy Diagnostic Market
Allergic diseases are the most common clinical diseases, mainly referring to IgE antibody-mediated type I immediate allergy. In addition to relying on a detailed and complete understanding of the medical history, physical examination, skin tests (pricks, intradermal tests) and provocation experiments, the clinical diagnosis of its clinical diagnosis is also one of the important components of the diagnosis of allergic diseases.
Due to the COVID-19 pandemic, the global Allergy Diagnostic market size is estimated to be worth US$ 5183.4 million in 2024 and is forecast to a readjusted size of US$ 6646.5 million by 2034 with a CAGR of 3.5% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Assay kits accounting for % of the Allergy Diagnostic global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Academic Institutes segment is altered to an % CAGR throughout this forecast period.
The global key players of allergy diagnostics include Thermo Fisher Scientific, PerkinElmer, bioMerieux. The global top three players hold a share over 20%. North Americas is the market, has a share over 40%, followed by Europe, with a share about 30%. In terms of product type, services for over 60%, which is the largest segment, while in terms of application, inhaled allergens is the largest segment, with a share of 40%.
Global Allergy Diagnostic Scope and Market Size
The global Allergy Diagnostic market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Allergy Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2018-2034.
Segment by Type
Assay kits
Consumables
Instruments
Academic Institutes
Diagnostic Laboratories
Hospitals
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
Thermo Fisher Scientific
BioMerieux
Hitachi Chemical Diagnostics
EUROIMMUN
HAL Allergy Group
Siemens
Stallergenes Greer
HOB Biotech Group (HOB)
Lincoln Diagnostics
Omega Diagnostics
Mediwiss
Allergic diseases are the most common clinical diseases, mainly referring to IgE antibody-mediated type I immediate allergy. In addition to relying on a detailed and complete understanding of the medical history, physical examination, skin tests (pricks, intradermal tests) and provocation experiments, the clinical diagnosis of its clinical diagnosis is also one of the important components of the diagnosis of allergic diseases.
Due to the COVID-19 pandemic, the global Allergy Diagnostic market size is estimated to be worth US$ 5183.4 million in 2024 and is forecast to a readjusted size of US$ 6646.5 million by 2034 with a CAGR of 3.5% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Assay kits accounting for % of the Allergy Diagnostic global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Academic Institutes segment is altered to an % CAGR throughout this forecast period.
The global key players of allergy diagnostics include Thermo Fisher Scientific, PerkinElmer, bioMerieux. The global top three players hold a share over 20%. North Americas is the market, has a share over 40%, followed by Europe, with a share about 30%. In terms of product type, services for over 60%, which is the largest segment, while in terms of application, inhaled allergens is the largest segment, with a share of 40%.
Global Allergy Diagnostic Scope and Market Size
The global Allergy Diagnostic market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Allergy Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2018-2034.
Segment by Type
Assay kits
Consumables
Instruments
Segment by Application
Academic Institutes
Diagnostic Laboratories
Hospitals
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Thermo Fisher Scientific
BioMerieux
Hitachi Chemical Diagnostics
EUROIMMUN
HAL Allergy Group
Siemens
Stallergenes Greer
HOB Biotech Group (HOB)
Lincoln Diagnostics
Omega Diagnostics
Mediwiss
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices